Short Information | Kodiak Sciences Inc (NASDAQ:KOD)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 966,746 |
Total Actual Volume | 5,965,069 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 48,337 |
Average Short Percentage | 18.74% |
Is there a KOD Short Squeeze or Breakout about to happen?
See the KOD Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-03-2024 | $2.24 | $2.2 | $2.26 | $2.185 | 167,198 | 39,622 | 23.7% |
07-02-2024 | $2.35 | $2.24 | $2.35 | $2.23 | 183,771 | 46,195 | 25.14% |
07-01-2024 | $2.39 | $2.37 | $2.43 | $2.31 | 238,271 | 26,634 | 11.18% |
06-28-2024 | $2.44 | $2.35 | $2.44 | $2.31 | 1,248,159 | 85,399 | 6.84% |
06-27-2024 | $2.31 | $2.43 | $2.45 | $2.25 | 484,431 | 51,120 | 10.55% |
06-26-2024 | $2.54 | $2.29 | $2.56 | $2.28 | 440,145 | 95,516 | 21.7% |
06-25-2024 | $2.72 | $2.53 | $2.72 | $2.52 | 251,218 | 75,438 | 30.03% |
06-24-2024 | $2.66 | $2.73 | $2.825 | $2.64 | 278,605 | 66,131 | 23.74% |
06-21-2024 | $2.55 | $2.64 | $2.6638 | $2.55 | 229,568 | 26,729 | 11.64% |
06-20-2024 | $2.61 | $2.52 | $2.62 | $2.49 | 176,199 | 42,263 | 23.99% |
06-18-2024 | $2.69 | $2.61 | $2.69 | $2.59 | 143,914 | 26,256 | 18.24% |
06-17-2024 | $2.75 | $2.69 | $2.75 | $2.5601 | 304,041 | 58,139 | 19.12% |
06-14-2024 | $2.73 | $2.81 | $2.87 | $2.69 | 194,133 | 36,544 | 18.82% |
06-13-2024 | $2.79 | $2.76 | $2.82 | $2.735 | 128,237 | 29,026 | 22.63% |
06-12-2024 | $2.92 | $2.79 | $3.06 | $2.77 | 149,527 | 23,524 | 15.73% |
06-11-2024 | $2.79 | $2.82 | $2.89 | $2.67 | 143,088 | 32,836 | 22.95% |
06-10-2024 | $2.85 | $2.78 | $2.86 | $2.75 | 465,259 | 76,041 | 16.34% |
06-07-2024 | $2.95 | $2.89 | $3 | $2.87 | 247,627 | 48,299 | 19.5% |
06-06-2024 | $3.17 | $3.01 | $3.17 | $2.975 | 246,480 | 46,899 | 19.03% |
06-05-2024 | $3.01 | $3.15 | $3.15 | $2.92 | 245,198 | 34,135 | 13.92% |
News, Short Squeeze, Breakout and More Instantly...
Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences PR Newswire PALO ALTO, Calif. , May 29, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transfor...
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results PR Newswire PALO ALTO, Calif. , May 15, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the qu...
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy PR Newswire PALO ALTO, Calif. , May 13, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to r...